| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +6% |
| 3Y CAGR | -8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -37% |
| 3Y CAGR | +46% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹21,505.00 +155.00 (0.73%) | 27,446.53 | 55.14 | 14.65 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,631.90 -84.50 (3.11%) | 20,590.05 | 30.37 | 6.11 | ||
PfizerPFIZER | ₹3,858.90 -16.40 (0.42%) | 17,730.22 | 24.12 | 4.22 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,031.00 -155.00 (2.51%) | 15,471.88 | 91.21 | 17.73 |